Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for March 5, 2020
SAGE
Get Breaking Institutional Stock News For
Free
with a 14 day trial
16:18 EST Sage Therapeutics initiated with a Buy at Citi
Mar 5, 2020 | 16:18 EDT
Citi analyst Neena Bitritto-Garg initiated coverage of Sage Therapeutics with a Buy rating and $71 price target.
News For SAGE From the Last 2 Days
SAGE
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Sage Therapeutics management to meet with Piper Sandler
Mar 26, 2024 | 07:45 EDT
SAGE
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Sage Therapeutics price target raised by $5 at JPMorgan, here's why
Mar 26, 2024 | 05:57 EDT